Related Experiment Videos
LMO2 and gene therapy for severe combined immunodeficiency
The New England Journal of Medicine
|June 11, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy.
Molecular therapy. Methods & clinical development·2024
The British Society for Gene and Cell Therapy at 20 (2003-2023).
Human gene therapy·2023
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation.
Life science alliance·2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells.
Nature communications·2023
Pregnancy in primary immunodeficiency diseases: The PREPI study.
The Journal of allergy and clinical immunology·2023
Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries.
The New England journal of medicine·2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.
Cancer immunology research·2026
Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.
Inflammatory intestinal diseases·2026